H. Lundbeck A/S (HLBBF)
7.10
0.00 (0.00%)
USD |
OTCM |
Oct 29, 16:00
H. Lundbeck Market Cap : 7.044B for Oct. 29, 2026
Market Cap Chart
Historical Market Cap Data
| Date | Value |
|---|---|
| October 29, 2026 | 7.044B |
| October 28, 2026 | 7.044B |
| October 27, 2026 | 7.044B |
| October 26, 2026 | 7.044B |
| October 23, 2026 | 7.044B |
| October 22, 2026 | 7.044B |
| October 21, 2026 | 7.044B |
| October 20, 2026 | 7.044B |
| October 19, 2026 | 7.044B |
| October 16, 2026 | 7.044B |
| October 15, 2026 | 7.044B |
| October 14, 2026 | 6.707B |
| October 13, 2026 | 6.707B |
| October 12, 2026 | 6.707B |
| October 09, 2026 | 6.707B |
| October 08, 2026 | 6.707B |
| October 07, 2026 | 6.707B |
| October 06, 2026 | 6.707B |
| October 05, 2026 | 6.707B |
| October 02, 2026 | 6.707B |
| October 01, 2026 | 6.707B |
| September 30, 2026 | 6.707B |
| September 29, 2026 | 6.707B |
| September 28, 2026 | 6.702B |
| September 25, 2026 | 6.702B |
| Date | Value |
|---|---|
| September 24, 2026 | 6.702B |
| September 23, 2026 | 6.702B |
| September 22, 2026 | 6.702B |
| September 21, 2026 | 6.702B |
| September 18, 2026 | 6.702B |
| September 17, 2026 | 6.702B |
| September 16, 2026 | 6.702B |
| September 15, 2026 | 6.702B |
| September 14, 2026 | 6.702B |
| September 11, 2026 | 6.905B |
| September 10, 2026 | 6.905B |
| September 09, 2026 | 6.905B |
| September 08, 2026 | 6.905B |
| September 04, 2026 | 6.905B |
| September 03, 2026 | 6.905B |
| September 02, 2026 | 6.905B |
| September 01, 2026 | 6.905B |
| August 31, 2026 | 6.905B |
| August 28, 2026 | 6.905B |
| August 27, 2026 | 6.905B |
| August 26, 2026 | 6.588B |
| August 25, 2026 | 6.588B |
| August 24, 2026 | 6.588B |
| August 21, 2026 | 6.588B |
| August 20, 2026 | 6.588B |
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Market Cap Benchmarks
| Novo Nordisk A/S | 130.96B |
| ALK-Abello A/S | 8.099B |
| Xeris Biopharma Holdings, Inc. | 1.866B |
| AstraZeneca PLC | 540.93B |
| ANI Pharmaceuticals, Inc. | 1.681B |
Market Cap Related Metrics
| PE Ratio | 11.61 |
| PS Ratio | 1.758 |
| PEG Ratio | 0.5468 |
| Price to Book Value | 1.714 |
| Price to Free Cash Flow | 9.781 |
| Price | 7.10 |
| Earnings Yield | 8.61% |
| PEGY Ratio | 0.4876 |
| Operating PE Ratio | 6.454 |
| Normalized PE Ratio | 9.804 |